相似文献
1
The human platelet fibrinogen receptor: clinical and therapeutic significance.
Br J Clin Pharmacol. 1992 Jan;33(1):3-9. doi: 10.1111/j.1365-2125.1992.tb03993.x.
2
PADGEM: an adhesion receptor for leukocytes on stimulated platelets and endothelial cells.
Proc Soc Exp Biol Med. 1991 Nov;198(2):703-9. doi: 10.3181/00379727-198-43309a.
3
Immunocytochemical aspects of platelet membrane glycoproteins and adhesive proteins during activation.
Prog Histochem Cytochem. 1996;30(1):1-106. doi: 10.1016/s0079-6336(96)80009-x.
4
Shear-induced platelet activation measured by flow cytometry.
Ann N Y Acad Sci. 1994 Apr 18;714:309-11. doi: 10.1111/j.1749-6632.1994.tb12064.x.
5
Monoclonal antibodies against platelet glycoproteins.
Transfus Med Rev. 1993 Jul;7(3):156-72. doi: 10.1016/s0887-7963(93)70135-2.
6
The action of ticlopidine on human platelets. Studies on aggregation, secretion, calcium mobilization and membrane glycoproteins.
Thromb Haemost. 1990 Aug 13;64(1):150-5.
7
8
The clinical significance of platelet membrane glycoproteins.
Hematol Oncol Clin North Am. 1990 Feb;4(1):87-105.
9
Lysosomal membrane glycoproteins in platelets.
Thromb Haemost. 1992 Oct 5;68(4):378-82.
10
Expression, regulation and detection of fibrinogen receptors on activated human platelets.
Prog Clin Biol Res. 1988;283:345-80.
引用本文的文献
1
Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes.
Sci Rep. 2021 Feb 22;11(1):4305. doi: 10.1038/s41598-021-82838-5.
2
Poly(Ethylene glycol)-based backbones with high peptide loading capacities.
Molecules. 2014 Oct 30;19(11):17559-77. doi: 10.3390/molecules191117559.
3
Ticlopidine. A review of its pharmacology, clinical efficacy and tolerability in the prevention of cerebral ischaemia and stroke.
Drugs Aging. 1996 Mar;8(3):214-32. doi: 10.2165/00002512-199608030-00006.
本文引用的文献
1
Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.
Proc Natl Acad Sci U S A. 1982 Jun;79(12):3711-5. doi: 10.1073/pnas.79.12.3711.
2
Correlation between fibrinogen binding to human platelets and platelet aggregability.
Blood. 1980 May;55(5):841-7.
3
Fibrinogen binding to human platelet plasma membranes. Identification of two steps requiring divalent cations.
J Biol Chem. 1983 Sep 10;258(17):10240-6.
4
Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
Proc Natl Acad Sci U S A. 1983 May;80(9):2417-21. doi: 10.1073/pnas.80.9.2417.
5
6
Identification of two structurally and functionally distinct sites on human platelet membrane glycoprotein IIb-IIIa using monoclonal antibodies.
J Biol Chem. 1983 Apr 25;258(8):5269-75.
7
In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
Agents Actions Suppl. 1984;15:97-104. doi: 10.1007/BF01966985.
8
Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis.
Br J Haematol. 1985 Jun;60(2):331-44. doi: 10.1111/j.1365-2141.1985.tb07419.x.
9
Effect of ticlopidine ex vivo on platelet intracellular calcium mobilization.
Thromb Res. 1988 Apr 1;50(1):65-76. doi: 10.1016/0049-3848(88)90175-2.
10
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders.
Blood. 1988 Apr;71(4):978-82.
Zotero 插件